Walder Wyss advised the investors while VISCHER acted as legal advisor to Nouscom in the transaction. Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized...
Nouscom’s €67.5 Million Oversuscribed Series C Financing Round
Iktos’ €15.5 Million Series A Financing
Jones Day advised Debiopharm Innovation Fund, M Ventures, and Omnes Capital on the deal. Iktos, a Paris, France-based company specializing in artificial intelligence for new drug...